• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.

Co-authoring Researcher

Co-inventing Researcher

Researcher similar to the Researcher

Article similar to the Researcher

Patent similar to the Researcher

Research Project similar to the Researcher

Article(J-GLOBAL estimation)

Patent(J-GLOBAL estimation)

Rchr
J-GLOBAL ID:200901009179469800   Update date: Apr. 15, 2025

Yoshiji Hitoshi

ヨシジ ヒトシ | Yoshiji Hitoshi
Clips
Affiliation and department:
Job title: Lecturer
Other affiliations (1):
  • 消化器代謝内科  教授
Homepage URL  (1): http://www.naramed-u.ac.jp/~3int/
Research field  (1): Gastroenterology
Research keywords  (10): portal hypertension ,  liver cirrhosis ,  血管新生 ,  NAFLD ,  肝線維化 ,  肝癌 ,  NASH ,  hepatocellular carcinoma ,  liver fibrosis ,  Angiogenesis
Research theme for competitive and other funds  (21):
  • 2024 - 2026 Pathophysiological analysis and therapeutic development based on vWF-ADAMTS13 regulation for poor prognostic factors in liver cirrhosis
  • 2022 - 2025 血液凝固制御因子ADAMTS13による急性肝不全新規治療法とバイオマーカーの開発
  • 2021 - 2024 Novel Liver Cirrhosis Treatment by Drug Repositioning and Leaky Gut Control
  • 2021 - 2024 歯周病と慢性肝疾患病態の関連解明-新たな肝疾患進展予防施策の探索
  • 2021 - 2023 Development research of novel pathophysiology and therapy for hepatorenal syndrome in cirrhosis-Thrombotic microangiopathy and recombinant ADAMTS13 therapy-
Show all
Papers (572):
  • Atsushi Tanaka, Masanori Abe, Tadashi Namisaki, Shinji Shimoda, Mikio Zeniya, Akio Ido, Hitoshi Yoshiji, Hiromasa Ohira, Kenichi Harada, Yuko Kakuda, et al. A placebo-controlled Phase 2 trial of E6011, anti-human fractalkine monoclonal antibody, in primary biliary cholangitis. JOURNAL OF TRANSLATIONAL AUTOIMMUNITY. 2025. 10
  • Yukihisa Fujinaga, Tadashi Namisaki, Yuki Tsuji, Akihiko Shibamoto, Takahiro Kubo, Aritoshi Koizumi, Takuya Matsuda, Takashi Inoue, Satoshi Iwai, Fumimasa Tomooka, et al. Fibrosis stage is an independent predictor of liver-related complications in primary biliary cholangitis. Hepatology Research. 2025
  • Hiroaki Takaya, Tadashi Namisaki, Yusuke Komeda, Hiroki Kinoshita, Naoki Nishimura, Yuki Tsuji, Shinya Sato, Norihisa Nishimura, Ko Saito, Shigeyuki Aizawa, et al. Low Intrahepatic Distant Recurrence Rate Following RFA Using Linear Mode in Patients With Hepatocellular Carcinoma. JGH OPEN. 2025. 9. 4
  • Hiroaki Takaya, Tadashi Namisaki, Yusuke Komeda, Hiroki Kinoshita, Naoki Nishimura, Yuki Tsuji, Shinya Sato, Norihisa Nishimura, Ko Saito, Shigeyuki Aizawa, et al. Low Intrahepatic Distant Recurrence Rate Following RFA Using Linear Mode in Patients With Hepatocellular Carcinoma. JGH open : an open access journal of gastroenterology and hepatology. 2025. 9. 4. e70145
  • Fumimasa Tomooka, Koh Kitagawa, Akira Mitoro, Yukihisa Fujinaga, Norihisa Nishimura, Tadashi Namisaki, Takemi Akahane, Kosuke Kaji, Shohei Asada, Shinya Sato, et al. Unilateral drainage and chemotherapy prolong the patency of a plastic stent placed above the sphincter of Oddi in patients with malignant hilar biliary obstruction. DEN open. 2025. 5. 1. e404
more...
MISC (976):
  • Norihisa Nishimura, Kosuke Kaji, Shinya Sato, Tadashi Namisaki, Hitoshi Yoshiji. TOFOGLIFLOZIN AMELIORATES PORTAL HYPERTENSION ALONG WITH LIVER FIBROSIS PROGRESSION BY INHIBITION OF SINUSOIDAL CAPILLARIZATION IN RATS WITH LIVER CIRRHOSIS. HEPATOLOGY. 2024. 80. S1625-S1625
  • Nagisa Hara, Atsushi Hiraoka, Masato Nakai, Makoto Shiraki, Tadashi Namisaki, Hisamitsu Miyaaki, Takuro Hisanaga, Hirokazu Takahashi, Hideko Ohama, Fujimasa Tada, et al. CLINICAL IMPACT OF HARM REDUCTION IN PATIENTS WITH CHRONIC LIVER DISEASE AND ALCOHOL USE DISORDER BY BRIEF INTERVENTION IN A HEPATOLOGY OUTPATIENT UNIT. HEPATOLOGY. 2024. 80. S1106-S1106
  • Kosuke Kaji, Norihisa Nishimura, Shinya Sato, Tadashi Namisaki, Hitoshi Yoshiji. GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST, SEMAGLUTIDE PREVENTS LIVER CIRRHOSIS-INDUCED SKELETAL MUSCLE ATROPHY IN DIABETIC MICE. HEPATOLOGY. 2024. 80. S1603-S1604
  • Shinya Sato, Hiroaki Takaya, Norihisa Nishimura, Kosuke Kaji, Tadashi Namisaki, Takemi Akahane, Hitoshi Yoshiji. DIABETES IS A RISK FACTOR FOR SARCOPENIA OF PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS-DRIVEN CIRRHOSIS. HEPATOLOGY. 2024. 80. S451-S452
  • Tadashi Namisaki, Shinya Sato, Kosuke Kaji, Norihisa Nishimura, Hitoshi Yoshiji. PROGNOSTIC SIGNIFICANCE OF SKELETAL MUSCLE MASS IN PATIENTS WITH ALCOHOLIC CIRRHOSIS. HEPATOLOGY. 2024. 80. S1110-S1110
more...
Patents (8):
Books (1):
  • 肝がん・肝硬変に対する栄養療法の新時代
    アークメディア 2012 ISBN:9784875831600
Education (2):
  • - 1993 Nara Medical University
  • - 1993 Nara Medical University Graduate School, Division of Medicine
Professional career (1):
  • (BLANK) (Nara Medical University)
Work history (14):
  • 2015/07 - 現在 奈良県立医大 消化器代謝内科 主任教授
  • 2015 - 現在 Nara Medical University Department of Gastroenterology Chairman and Full Professor
  • 2012 - 現在 奈良県立医大 准教授
  • 2012 - 2015 Nara Medical University Department of Gastroenterology Associate Professor
  • 2007 - 2012 Nara Medical University Department of Gastroenterology Lecturer
Show all
Committee career (10):
  • - 現在 肝臓学会・糖尿病学会合同「肝と糖尿病・代謝研究会」委員
  • 門脈圧亢進症学会理事
  • 消化器内視鏡学会社団評議員
  • 次世代再生医療肝再生審査部WG座長
  • 日本医療安全審査機構 事例審査部会長
Show all
Awards (7):
  • 2023/06 - The Japan Society of Hepatology Award of The Japan Society of Hepatology Pathological analysis and treatment development of liver cirrhosis
  • 2003 - 日本肝臓学会研究奨励賞(Hepatology Research賞)
  • 2003 - 奈良県立医科大学研究奨励賞
  • 2001 - 日本癌転移学会研究奨励賞
  • 2000 - 日本ウイルス肝炎財団奨励賞
Show all
Association Membership(s) (10):
NYAS (New York Academy of Science) ,  AACR (American Association of Cancer Research) ,  日本消化器内視鏡学会 ,  日本肝臓学会 ,  アメリカ癌学会 ,  日本癌学会 ,  日本消化器病学会 ,  日本内科学会 ,  欧州肝臓学会 ,  American Association of the study of liver diseases
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page